LABCORP HOLDINGS INC. — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-12

Reporting Person: Caveney Brian J (EVP, President of Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	M	233	—	Acquired	556.3903	Direct
2020-02-12	Common Stock	F	82	$187.51	Disposed	474.3903	Direct
2020-02-12	Common Stock	M	283	—	Acquired	757.3903	Direct
2020-02-12	Common Stock	F	86	$187.51	Disposed	671.3903	Direct
2020-02-12	Common Stock	M	2353	—	Acquired	3024.3903	Direct
2020-02-12	Common Stock	F	698	$187.51	Disposed	2326.3903	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Restricted Stock Unit	$	M	233	Disposed		Common Stock (233)	Direct
2020-02-12	Restricted Stock Unit	$	M	283	Disposed		Common Stock (283)	Direct
2020-02-12	Restricted Stock Unit	$	M	2353	Disposed		Common Stock (2353)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 105.4961 shares acquired on June 28, 2019 and 66.8942 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F6: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.